~61 spots leftby Aug 2026

EWM Training for ADHD

Recruiting in Palo Alto (17 mi)
MC
Overseen byMichael C Stevens, PhD
Age: < 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Hartford Hospital
Disqualifiers: Psychosis, Bipolar, ASD, others

Trial Summary

What is the purpose of this trial?

The proposed study will replicate target engagement as assessed in the first phase while also determining if it correlates with clinically meaningful improvements in ADHD dysfunction

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the EWM Training treatment for ADHD?

Some studies suggest that working memory training can improve working memory and inhibitory control in children with ADHD, and may help reduce ADHD symptoms at home and school. However, other research indicates that while working memory training can enhance short-term memory tasks, it may not significantly improve classic ADHD symptoms like attention problems or impulsivity.12345

Is EWM Training for ADHD safe for humans?

The research articles reviewed do not provide specific safety data for EWM Training or similar interventions like placebo treatments in ADHD. They focus on the effects of placebo in ADHD treatment but do not address safety concerns directly.678910

How is EWM Training different from other ADHD treatments?

EWM Training is unique because it focuses on improving working memory through computerized exercises, which is different from traditional ADHD treatments that often involve medication or behavioral therapy. This approach aims to enhance cognitive skills by practicing memory tasks that gradually increase in difficulty.1251112

Research Team

MC

Michael C Stevens, PhD

Principal Investigator

Institute of Living/Hartford Hospital

Eligibility Criteria

This trial is for individuals diagnosed with ADHD. Specific eligibility criteria are not provided, so it's important to contact the study organizers for detailed information on who can participate.

Inclusion Criteria

Diagnosis of ADHD
English speaking
Right-handed
See 2 more

Exclusion Criteria

I have a brain condition or neurological disorder.
Braces, metal, or implant devices
I have had a traumatic brain injury or was unconscious for over 30 minutes.
See 1 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo executive working memory (EWM) training or placebo sessions 4 times each week for 5 weeks

5 weeks
Remote sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment, including changes in fMRI measurements and performance on cognitive tasks

4 weeks

Treatment Details

Interventions

  • EWM Training (Behavioral Intervention)
  • Placebo Training (Behavioral Intervention)
Trial OverviewThe study is testing a training called EWM Training against a Placebo Training to see if it helps improve executive working memory and reduces symptoms of ADHD.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: ADHD EWMExperimental Treatment1 Intervention
Participants will receive EWM training sessions.
Group II: ADHD PlaceboPlacebo Group1 Intervention
Participants will receive placebo training sessions.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Institute of Living/Hartford HospitalHartford, CT
Loading ...

Who Is Running the Clinical Trial?

Hartford Hospital

Lead Sponsor

Trials
140
Patients Recruited
19,700+

Findings from Research

Commentary: Working memory training and ADHD - where does its potential lie? Reflections on Chacko et al. (2014).Gathercole, SE.[2022]
RCT of working memory training in ADHD: long-term near-transfer effects.Hovik, KT., Saunes, BK., Aarlien, AK., et al.[2021]
Methylphenidate and memory: dissociated effects in hyperactive children.Evans, RW., Gualtieri, CT., Amara, I.[2019]
The effect of comprehensive working memory training on executive functions and behavioral symptoms in children with attention deficit-hyperactivity disorder (ADHD).Nejati, V., Derakhshan, Z., Mohtasham, A.[2023]
Computerized working memory training for adults with ADHD in a psychiatric outpatient context-a feasibility trial.Sjöwall, D., Berglund, M., Hirvikoski, T.[2023]
Responders, nonresponders, and placebo responders among children with attention deficit disorder. Importance of a blinded placebo evaluation.Ullmann, RK., Sleator, EK.[2017]
Placebo and nocebo responses in randomised, controlled trials of medications for ADHD: a systematic review and meta-analysis.Faraone, SV., Newcorn, JH., Cipriani, A., et al.[2022]
Magnesium pemolone: lack of facilitation in human learning, memory, and performance tests.Smith, RG.[2019]
The use of actigraphy in the monitoring of methylphenidate versus placebo in ADHD: a meta-analysis.De Crescenzo, F., Armando, M., Mazzone, L., et al.[2014]
Placebo response and its determinants in children with ADHD across multiple observers and settings: A randomized clinical trial.Fageera, W., Traicu, A., Sengupta, SM., et al.[2021]
Predictors and Moderators of Treatment Outcome in Cognitive Training for Children With ADHD.van der Donk, MLA., Hiemstra-Beernink, AC., Tjeenk-Kalff, AC., et al.[2021]
Computerized training of working memory in children with ADHD--a randomized, controlled trial.Klingberg, T., Fernell, E., Olesen, PJ., et al.[2022]

References

Commentary: Working memory training and ADHD - where does its potential lie? Reflections on Chacko et al. (2014). [2022]
RCT of working memory training in ADHD: long-term near-transfer effects. [2021]
Methylphenidate and memory: dissociated effects in hyperactive children. [2019]
The effect of comprehensive working memory training on executive functions and behavioral symptoms in children with attention deficit-hyperactivity disorder (ADHD). [2023]
Computerized working memory training for adults with ADHD in a psychiatric outpatient context-a feasibility trial. [2023]
Responders, nonresponders, and placebo responders among children with attention deficit disorder. Importance of a blinded placebo evaluation. [2017]
Placebo and nocebo responses in randomised, controlled trials of medications for ADHD: a systematic review and meta-analysis. [2022]
Magnesium pemolone: lack of facilitation in human learning, memory, and performance tests. [2019]
The use of actigraphy in the monitoring of methylphenidate versus placebo in ADHD: a meta-analysis. [2014]
10.United Statespubmed.ncbi.nlm.nih.gov
Placebo response and its determinants in children with ADHD across multiple observers and settings: A randomized clinical trial. [2021]
11.United Statespubmed.ncbi.nlm.nih.gov
Predictors and Moderators of Treatment Outcome in Cognitive Training for Children With ADHD. [2021]
12.United Statespubmed.ncbi.nlm.nih.gov
Computerized training of working memory in children with ADHD--a randomized, controlled trial. [2022]